LifeStance Health Group, Inc. (LFST): Results of Operations and Financial Condition
LifeStance Health Group, Inc. (LFST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 lfst-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 investor.relations@lifestance.com LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook Announc
How this was made
The 30-second read
Why it matters
The filing provides a complete earnings-and-guidance package plus a new $100M share repurchase authorization, which can drive both fundamental repricing and near-term sentiment.
Market read
Traders can update models immediately using the disclosed Q2 metrics, FY2026 guidance ranges, and Q3 outlook, and assess capital return via the repurchase program.
What to watch
Net long-term debt of $259.0M and the pace of free cash flow conversion versus repurchase execution could matter for valuation and credit risk.
Background
This is an SEC 8-K (Item 2.02) with LifeStance’s Q2 2026 results, cash flow/capital allocation updates, and updated 2026 outlook.
Ticker impact
LifeStance reported Q2 revenue of $435.4M (+26% YoY), net income $23.6M, and raised FY2026 guidance plus a $100M buyback.
Near-term upside bias as traders price in higher 2026 profitability and capital return; follow-through depends on Q3 guide range.
The filing discloses multiple fresh, decision-relevant datapoints: quarterly results, explicit FY and Q3 guidance ranges, and a board-approved $100M repurchase program.
Market effects
Signals improving operating leverage and profitability trajectory for outpatient mental healthcare operators, potentially affecting read-across sentiment.
No specific regional catalyst beyond nationwide center footprint expansion.
Primarily US-focused healthcare services; limited direct global market linkage.
Counterpoint
Guidance raises expectations, but the Q3 revenue and Adjusted EBITDA ranges could still disappoint if visit growth or center margin trends slow.
Key entities
- public_companyLifeStance Health Group, Inc.
Outpatient mental healthcare provider reporting Q2 2026 results and raising FY2026 guidance; authorizes up to $100M share repurchases.
- executiveDave Bourdon
CEO quoted on the quarter’s performance and growth outlook.
